Skip to content

Clinical trials

Osteoporosis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Country / region: Hong Kong Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20061
20072
20082
20111
20122
20171
20181
20193
20212
20222
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Not yet recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
The University of Hong Kong3
Kowloon Hospital, Hong Kong2
Prince of Wales Hospital, Shatin, Hong Kong2
Radius Health, Inc.2
Amgen1
Eli Lilly and Company1
GlaxoSmithKline1
Kwong Wah Hospital1
Ligand Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis22
Bone Diseases, Metabolic5
Osteoporosis, Postmenopausal4
Sarcopenia3
Fractures, Bone2
Anxiety Disorders1
Bone Diseases1
Breast Neoplasms1
Colorectal Neoplasms1
Hip Fractures1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.